Pycnogenol May Ease Pain for Women With Low Bone Density

A small, preliminary trial suggests the supplement could improve pain and vitality scores for women with bone density issues.

Updated on Oct. 16, 2026 in Nutrition

Gouache-painted illustration of maritime pine needles and bark, evoking natural health and wellness themes for a study on bone density.
A clinical study published in January 2024 suggests that daily Pycnogenol supplementation may help improve pain and vitality scores for women with osteopenia or osteoporosis. AI Illustration. Upload story photo >

Live Poll

Do you trust dietary supplements to effectively manage your chronic pain or improve your vitality?

A six-month clinical trial published in January 2024 evaluated the effects of Pycnogenol supplementation on quality of life in women with osteopenia or osteoporosis. While participants reported improvements in pain and vitality, researchers noted that further studies are needed to confirm these findings.

Why it matters

Managing chronic conditions like osteopenia and osteoporosis requires balancing bone health with overall well-being, as pain and fatigue can significantly impact daily quality of life. This research explores whether specific nutritional interventions could offer supportive benefits alongside standard management.

This randomized clinical trial enrolled 67 women with osteopenia or osteoporosis, comparing 100 mg of Pycnogenol taken twice daily against a placebo. While pain and vitality scores showed significant improvement after three months, the overall quality of life remained statistically similar between groups.

The players

Horphag Research

A developer and supplier of Pycnogenol that provided an educational grant for this clinical study.

The details

The study randomized participants into two groups to observe the effects of daily Pycnogenol supplementation over an initial three-month phase and a three-month extension. Researchers tracked participant outcomes through the SF-36v2 bodily pain domain and the QUALEFFO-41 quality-of-life questionnaire. Throughout the trial, liver enzyme and renal function levels remained stable in both groups, and no moderate or serious adverse events occurred.

Timeline

  1. October 2021 to January 2024: Enrollment of study participants.

  2. 3 months: Initial treatment phase.

  3. 6 months: Full duration of the clinical trial.

Health Landscape

This research is part of a broader, ongoing investigation into potential nutritional support strategies for women managing osteopenia and osteoporosis. It adds to the medical community's efforts to identify interventions that may improve patient-reported symptoms alongside standard bone-density care.

If you are managing osteopenia or osteoporosis, these preliminary results highlight the importance of discussing all supplement use with your physician to ensure safety. Your medical team can help evaluate which interventions may be appropriate based on your specific health history and treatment plan.

The takeaway

While early data on Pycnogenol suggests potential benefits for pain and vitality in women with low bone density, these findings are preliminary and do not replace established medical guidance. Always consult your healthcare provider before adding new supplements to your daily routine.

Further reading

Explore the latest evidence on supportive dietary strategies at Nutrition.

Source note: This article includes information reported by News-Medical.

Live Poll

Do you trust dietary supplements to effectively manage your chronic pain or improve your vitality?